Epperla N et al. |
Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy. |
2017 |
Transfusion |
pmid:28836275
|
Wiebe C et al. |
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28729289
|
Das B et al. |
Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients. |
2017 |
Pediatr Transplant |
pmid:27862703
|
Abongwa C et al. |
Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient. |
2017 |
Pediatr Blood Cancer |
pmid:28598573
|
Tamashiro EY et al. |
Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. |
2017 |
Drug Metab Pers Ther |
pmid:28593920
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Ramirez R et al. |
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. |
2017 |
Am J Case Rep |
pmid:28465499
|
Zheng X et al. |
Effect of FK-506 (tacrolimus) therapy on bone healing of titanium implants: a histometric and biomechanical study in mice. |
2017 |
Eur. J. Oral Sci. |
pmid:27935130
|
Song K et al. |
Engineering of the LysR family transcriptional regulator FkbR1 and its target gene to improve ascomycin production. |
2017 |
Appl. Microbiol. Biotechnol. |
pmid:28349163
|
Wan T et al. |
Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities. |
2017 |
Int J Nanomedicine |
pmid:28260894
|
Ferjani H et al. |
Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats. |
2017 |
Exp. Biol. Med. (Maywood) |
pmid:26582055
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Vanhove T et al. |
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28168728
|
Qin HZ et al. |
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients. |
2017 |
BMC Nephrol |
pmid:28056860
|
Dong Y et al. |
Risk Factors, Clinical Features, and Treatment Outcomes of Recurrent Mooren Ulcers in China. |
2017 |
Cornea |
pmid:28060068
|
Dutta D et al. |
Recruitment of calcineurin to the TCR positively regulates T cell activation. |
2017 |
Nat. Immunol. |
pmid:27941787
|
Naicker D et al. |
Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28660366
|
Kannegieter NM et al. |
Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation. |
2017 |
Ther Drug Monit |
pmid:28640063
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|